Patients characteristics No. %
Age
< or equal 56 years
>56 years
44-76 with median 56 y- mean 57.9 ± 7.8
86 53 61,9 38.1
Sex
Male
Female
119
20
85.6
14.4
Alpha fetoprotein
<20
20-400
>400
10
27
102
7.2
19.4
73.4
Cirrhosis
Present
Absent
87
52
62.6
37.4
Viral hepatitis
Present
Absent
88
51
63.3
36.7
BCLC
A1
A2
A3
A4
B
C
D
28
31
24
14
6
20
16
20.1
22.3
17.3
10.1
4.3
14.4
11.5
Portal vein thrombosis
Yes
No
76
63
54.7
45.3
Serum bilirubin
<1.1
>1.1
59 80 42.4 57.6
ALP
20-140IU/l
>140 IU/L
47
92
33.8
66.2
AST
≤38
>38
23 116 16.5 83.5
ALT
≤38
>38
24
115
17.3
82.7
Albumin level
3.5-5.5g/L
<3.5gm/L
52
87
37.4
62.6
Prothrombin time(PT)
9.5-13.5 sec
>13.5 sec
82
57
59
41
Number of tumors
Single
Multiple
53
86
38.1
69.1
Size of tumor
<5 cm
5 cm-less than 50%
More than 50%
37
60 42
26.6
43.2 30.2
Hepatic metastases
No
Yes
119
20
86.3
17.3
Serum p53
Negative
Positive
122
17
87.8
12.2
Treatment
surgical resection
radiofrequency
TACE
Chemotherapy
No treatment
11
18
34
5
71
7.9
12.9
24.5
3.6
51.1
Table 1: characteristics of 139 cases with hepatocellular carcinoma